p21 Inhibits Thr161 Phosphorylation of Cdc2 to Enforce the G2 DNA Damage Checkpoint
Open accessThe DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Abstract
The cyclin-dependent kinase inhibitor p21 is required for a sustained G(2) arrest after activation of the DNA damage checkpoint. Here we have addressed the mechanism by which p21 can contribute to this arrest in G(2). We show that p21 blocks the activating phosphorylation of Cdc2 on Thr(161). p21 does not interfere with the dephosphorylation of two inhibitory phosphorylation sites on Cdc2, Thr(14) and Tyr(15), indicating that p21 targets a different event in Cdc2 activation as the well described DNA damage checkpoint pathway involving Chk1 and Cdc25C. Taken together our data show that a cell is equipped with at least two independent pathways to ensure efficient inhibition of Cdc2 activity in response to DNA damage, influencing both positive and negative regulatory phosphorylation events on Cdc2.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“even after its overexpression in U2OS osteosarcoma cancer cells, p21 only weakly associated with cyclin B1-Cdk1).58”
From Senescence from G2 arrest, revisited (2015) · cites this paper as [58]
In the citing paper
“They elegantly confirmed and extended previous observations 58,69 and pinpointed this event as the first step in triggering the G2 exit program, resulting in permanent cell cycle withdrawal (Fig. 3).”
From Senescence from G2 arrest, revisited (2015) · cites this paper as [58]
Citations
Cites
WAF1, a potential mediator of p53 tumor suppression
El-Deiry, W. S., Tokino, T., Velculescu, V. E., Levy, D. B., Parsons, R., Trent, J. M., Lin, D., Mercer, W. E., Kinzler, K. W., & Vogelstein, B. (1993) · Cell · doi:10.1016/0092-8674(93)90500-p · Cited by 8,321
Morgan, D. O. (1995) · Nature · doi:10.1038/374131a0 · Cited by 3,284
Requirement for p53 and p21 to Sustain G 2 Arrest After DNA Damage
Bunz, F., Dutriaux, A., Lengauer, C., Waldman, T., Zhou, S., Brown, J. P., Sedivy, J. M., Kinzler, K. W., & Vogelstein, B. (1998) · Science · doi:10.1126/science.282.5393.1497 · Cited by 2,803
Boyle, W. J., van der Geer, P., & Hunter, T. (1991) · Methods in Enzymology · doi:10.1016/0076-6879(91)01013-r · Cited by 1,434
Cyclin A is required at two points in the human cell cycle.
Pagano, M., Pepperkok, R., Verde, F., Ansorge, W., & Draetta, G. (1992) · The EMBO Journal · doi:10.1002/j.1460-2075.1992.tb05135.x · Cited by 1,403
Peng, C.-Y., Graves, P. R., Thoma, R. S., Wu, Z., Shaw, A. S., & Piwnica-Worms, H. (1997) · Science · doi:10.1126/science.277.5331.1501 · Cited by 1,341
Sanchez, Y., Wong, C., Thoma, R. S., Richman, R., Wu, Z., Piwnica-Worms, H., & Elledge, S. J. (1997) · Science · doi:10.1126/science.277.5331.1497 · Cited by 1,320
Is a p53-Regulated Inhibitor of G2/M Progression
Hermeking, H., Lengauer, C., Polyak, K., He, T.-C., Zhang, L., Thiagalingam, S., Kinzler, K. W., & Vogelstein, B. (1997) · Molecular Cell · doi:10.1016/s1097-2765(00)80002-7 · Cited by 1,251
Inhibition of cyclin-dependent kinases by p21.
Harper, J. W., Elledge, S. J., Keyomarsi, K., Dynlacht, B., Tsai, L. H., Zhang, P., Dobrowolski, S., Bai, C., Connell-Crowley, L., & Swindell, E. (1995) · Molecular Biology of the Cell · doi:10.1091/mbc.6.4.387 · Cited by 1,023
Hotamisligil, G. S., Johnson, R. S., Distel, R. J., Ellis, R., Papaioannou, V. E., & Spiegelman, B. M. (1996) · Science · doi:10.1126/science.274.5291.1377 · Cited by 918
Research works printed but not linked: 1
- Li, 1994, Oncogene, 9, 2261
Cited by
Items 101–200 of 231
Oridonin induces G2/M cell cycle arrest and apoptosis in human oral squamous cell carcinoma
Wang, H., Zhu, L., Feng, X., Zhang, H., Luo, Q., & Chen, F. (2017) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2017.09.021 · Cited by 29
“…suppressor activates many genes that encode proteins which are inducers of G2/M arrest, including p21, Gadd45, and 14-3-3σ. p21 inhibits the activity of cdc2 directly (Smits et al., 2000), and Gadd45 binds to cdc2 and dissociates the cyclin B1 subunit, thus inactivating the cdc2-cyclin B1 complex.”
BackgroundJu, J.-H., Yang, W., Oh, S., Nam, K., Lee, K., Noh, D., & Shin, I. (2013) · Biochemical Journal · doi:10.1042/bj20121716 · Cited by 29
Lee, Y. S., Ahmed, M. B., Alghamdi, A. A. A., Islam, S. U., & Ahsan, H. (2022) · Mini-Reviews in Medicinal Chemistry · doi:10.2174/1389557522666220826141837 · Cited by 31
Liu, X., Wang, J., Sun, B., Zhang, Y., Zhu, J., & Li, C. (2007) · Investigational New Drugs · doi:10.1007/s10637-007-9057-4 · Cited by 27
“G2M arrest in many cell types, and this change is largely caused by p53 [20, 21 ], we also evaluated the expression of p53 and p21.”
BackgroundStathmin-deficient mice develop fibrosis and show delayed recovery from ischemic-reperfusion injury
Zahedi, K. A., Revelo, M. P., Barone, S., Wang, Z., Tehrani, K., Citron, D. P., Bissler, J. J., Rabb, H., & Soleimani, M. (2006) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00424.2005 · Cited by 27
Tao, L., Fu, R., Wang, X., Yao, J., Zhou, Y., Dai, Q., Li, Z., Lu, N., & Wang, W. (2014) · Toxicology Letters · doi:10.1016/j.toxlet.2014.04.002 · Cited by 26
DeInnocentes, P., Agarwal, P., & Bird, R. C. (2009) · Journal of Cellular Biochemistry · doi:10.1002/jcb.22034 · Cited by 28
“CDK activity is controlled at multiple levels including transcription and degradation of its cyclin cofactor, post-translational modification of both cyclin and CDK and through association with a complex family of cyclin-dependent kinase inhibitors (CKIs) to form CDK integration complexes [Pavletich, 1999; Smits et al…”
BackgroundMultiple pathways were involved in tubeimoside-1-induced cytotoxicity of HeLa cells
Yang, X., Ching, Y.-P., Zhou, Y., Chiu, J., Chen, F., & He, Q. (2011) · Journal of Proteomics · doi:10.1016/j.jprot.2011.08.014 · Cited by 25
Granada, J. F., Ensenat, D., Keswani, A. N., Kałuża, G. L., Raizner, A. E., Liu, X., Peyton, K. J., Azam, M. A., Wang, H., & Durante, W. (2005) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000184779.01822.9d · Cited by 25
Yang, X., & Wang, G. (2021) · Journal of Medical Imaging · doi:10.31916/sjmi2021-01-02 · Cited by 25
Hao, X., Feng, P., Zhang, Y., Wang, F.-Z., Wang, G., & Fei, H. (2023) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2023.110487 · Cited by 26
Melanoma antigen A12 regulates cell cycle via tumor suppressor p21 expression
Yanagi, T., Nagai, K., Shimizu, H., & Matsuzawa, S. (2017) · Oncotarget · doi:10.18632/oncotarget.19497 · Cited by 25
“p21 is required in order to maintain G2 arrest by blocking the interaction of Cdk1 with Cdk activating kinase [21], which suggests that p21 accumulation is sufficient to arrest the cell cycle.”
BackgroundLong, D., & Wu, Y. (2008) · Toxicology Letters · doi:10.1016/j.toxlet.2008.06.871 · Cited by 24
Khandelwal, P., Padala, M. K., Cox, J. V., & Guntaka, R. V. (2009) · International Journal of Cell Biology · doi:10.1155/2009/243532 · Cited by 29
“In order to test whether the putative truncated protein could be responsible for the previously observed results, we developed an expression cassette containing the amino-terminal 77 amino acids of YB-1 inserted between the 16 amino acid antennapedia peptide and a GFP reporter.”
BackgroundHu, P., Zuo, Z., Li, H., Wang, F., Peng, X., Fang, J. S., Cui, H., Gao, C., Song, H., Zhou, Y., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-20164-z · Cited by 24
Hanna, D. H., Aziz, M. M., & Shafee, E. E. (2023) · Biotechnology and Applied Biochemistry · doi:10.1002/bab.2456 · Cited by 27
Li, P., Liu, X., Zhao, T., Li, F., Wang, Q., Zhang, P., Hirayama, R., Chen, W., Jin, X., Zheng, X., et al. (2021) · Cell Death Discovery · doi:10.1038/s41420-021-00570-5 · Cited by 23
“The inhibition of Cdc2 phosphorylation at Thr161 site can enhance the G2-M checkpoint [12].”
BackgroundLi, Z., Xie, Y., Sheng, W., Miao, J., Xiang, J., & Yang, J. (2010) · Cancer Biotherapy and Radiopharmaceuticals · doi:10.1089/cbr.2010.0778 · Cited by 22
Eapen, A. K., Henry, M. K., Quelle, D. E., & Quelle, F. W. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.18.6113-6121.2001 · Cited by 24
“Since there is no prior evidence that a CAK is inhibited or a phosphatase activated in response to DNA damage in other cell types, it is possible that this response to DNA damage is a unique property of hematopoietic cells.”
BackgroundInfluentialChang, J., Tien, N., Chang, Y., Lin, M., & Chen, S. (2021) · Cells · doi:10.3390/cells10061280 · Cited by 21
“Thr 161 phosphorylation is critical for maintenance of CDK1 kinase activity during the stage of mitosis [19,21], which is negatively regulated by the cyclin-dependent kinase inhibitor p21 [22].”
BackgroundUdden, S. M. N., Morita‐Fujimura, Y., Satake, M., & Ikawa, S. (2013) · Cellular Signalling · doi:10.1016/j.cellsig.2013.10.005 · Cited by 19
Adorisio, S., Fierabracci, A., Gigliarelli, G., Muscari, I., Cannarile, L., Liberati, A. M., Marcotullio, M. C., Riccardi, C., Curini, M., Robles‐Zepeda, R. E., et al. (2017) · Integrative Cancer Therapies · doi:10.1177/1534735416688413 · Cited by 19
“During the G 1 /S transition and G 2 phase, p21 inhibits Cdk-activating kinase (CAK) and its consequent Thr116 phosphorylation.(29) The protein can also interact with the cyclin B1-Cdk1 complex in response to genotoxic stress, thus blocking activation by Cdc25 and CAK,(30) and sustain G 2 arrest by mediating cyclin B1…”
BackgroundRetractedCui, L., Liang, B., Yang, Y., Zhu, M., Kwong, J., Zheng, H., & Wang, C. C. (2017) · Oncotarget · doi:10.18632/oncotarget.21356 · Cited by 17
“It was shown that p21 inhibits Cdc2/cyclin B1 complex and G2/M transition even with a weak affinity with the complex [49, 50].”
BackgroundYao, C., Yang, C.-M., Chuang, S., Yan, J.-L., Liu, C., Chen, S.-W., YAN, K.-H., Lai, T.-Y., & Lai, G. (2009) · Evidence-based Complementary and Alternative Medicine · doi:10.1093/ecam/nep165 · Cited by 16
“In addition, a broad-spectrum CDK inhibitor p21 [25] was also markedly increased by EAS5 (Figure 11).”
BackgroundQuantitative Proteomics Reveals Middle Infrared Radiation-Interfered Networks in Breast Cancer Cells
Chang, H., Li, M., Huang, T., Hsu, C., Tsai, S.-R., Lee, S., Huang, H., & Juan, H. (2015) · Journal of Proteome Research · doi:10.1021/pr5011873 · Cited by 16
Xu, D., Cao, J., Qian, S., Li, L., Hu, C., Weng, Q., Lou, J.-S., Zhu, D., Zhu, H., Hu, Y., et al. (2010) · Investigational New Drugs · doi:10.1007/s10637-010-9423-5 · Cited by 16
“of Thr161. Accordingly, there are at least two independent pathways to block Cdc2 upon activation of the G2 DNA damage checkpoint [ 23 ].”
BackgroundCruz, J. F. D., Kim, Y. S., Lumbera, W. M. L., & Hwang, S. G. (2015) · Asian Pacific Journal of Cancer Prevention · doi:10.7314/apjcp.2015.16.15.6417 · Cited by 16
“, 2006) inhibition of activating phosphorylation of Cdks (Smits et al., 2000) or induction of the Cdk inhibitor p21 (Dulis et al.”
BackgroundInfluentialNeuteboom, S., Karjian, P. L., Boyer, C. R., Beryt, M., Pegram, M. D., Wahl, G. M., & Shepard, H. M. (2002) · PubMed · Cited by 18
DeSimone, J. N., Bengtsson, U., Wang, X., Lao, X., Redpath, J. L., & Stanbridge, E. J. (2003) · Radiation Research · doi:10.1667/0033-7587(2003)159[0072:cotmoi]2.0.co;2 · Cited by 17
“Another mechanism that acts to delay the activation of the cyclin B1/CDC2 kinase involves the CDK inhibitor CDKN1A, which may contribute to the G2-phase arrest by blocking the activating phosphorylation of CDC2 on Thr161 (21).”
BackgroundCoyle, J. P., Johnson, C., Jensen, J., Farcas, M. T., Derk, R. C., Stueckle, T. A., Kornberg, T. G., Rojanasakul, Y., & Rojanasakul, L. W. (2023) · Scientific Reports · doi:10.1038/s41598-023-35310-5 · Cited by 17
Liu, J., Sheng, W., Xie, Y., Shan, Y., Miao, J., Xiang, J., & Yang, J. (2010) · Cancer Biotherapy and Radiopharmaceuticals · doi:10.1089/cbr.2009.0706 · Cited by 15
“…Cip = Kip family belonging to cdk inhibitors, which can inhibit the activity of cyclin E-CDK2, cyclin D-CDK4, and cyclin B1 = CDC2 complexes leading to G1 and G2 = M arrest, 32,33 and interact with proliferating cell nuclear antigen (PCNA) involved in S-phase DNA replication and DNA damage repair.”
Zhao, Y., Li, Z., Sheng, W., Miao, J., & Yang, J. (2012) · Oncology Reports · doi:10.3892/or.2012.1930 · Cited by 15
Rivas, V., González-Muñoz, T., Albitre, Á., Lafarga, V., Delgado‐Arévalo, C., Mayor, F., & Penela, P. (2024) · Cell Death Discovery · doi:10.1038/s41420-024-02143-8 · Cited by 17
“HeLa-SX(p53) cells were transfected with empty vector, GRK2-wt or GRK2-K220R, and antibiotic-selected cells were collected as pooled positive transfectants as reported [91].”
MethodMonahan, P., Himes, A. D., Parfieniuk, A., & Raetzman, L. T. (2011) · Mechanisms of Development · doi:10.1016/j.mod.2011.11.002 · Cited by 14
Manganese induces p21 expression in PC12 cells at the transcriptional level
Zhao, F., Zhang, J.-B., Cai, T., Liu, X., Liu, M.-C., Ke, T., Chen, J.-Y., & Luo, W. (2012) · Neuroscience · doi:10.1016/j.neuroscience.2012.04.027 · Cited by 13
Yang, X., Ye, X., Sun, L., Gao, F., Li, Y., Ji, X., Wang, X., Feng, Y., & Wang, X. (2017) · Oncotarget · doi:10.18632/oncotarget.18010 · Cited by 14
Lin, L., Hsu, S., Wu, C., Liu, W., & Hsueh, C. (2011) · Cellular Signalling · doi:10.1016/j.cellsig.2011.05.018 · Cited by 14
Hung, K.-C., Wang, S., Lin, M., & Chen, S. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20092105 · Cited by 13
“Ectopic expression of p21 can block the phosphorylation of CDK1 (Thr161) by CDK-activating kinase [47].”
BackgroundMechanisms of Hepatitis B Virus-Induced Hepatocarcinogenesis
Lee, J., Tsai, K.-N., & Ou, J. J. (2020) · Recent results in cancer research/Recent Results in Cancer Research · doi:10.1007/978-3-030-57362-1_3 · Cited by 12
Afrasiabi, E., Blom, T., Balthasar, S., & Törnquist, K. (2007) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2007.05.016 · Cited by 12
“Phosphorylation of Thr-161 is usually associated with enhanced activity of Cdc2 (Smits et al., 2000).”
BackgroundSkwarska, A., Ramachandran, S., Dobrynin, G., Leszczyńska, K. B., & Hammond, E. M. (2017) · Oncotarget · doi:10.18632/oncotarget.16102 · Cited by 12
Transient suppression of nuclear Cdc2 activity in response to ionizing radiation
Kim, M., Lee, J.-Y., & Lee, S. (2008) · Oncology Reports · doi:10.3892/or.19.5.1323 · Cited by 12
The role of p53/p21/p16 in DNA damage signaling and DNA repair
Kulaberoglu, Y., Hergovich, A., & Gómez, V. (2021) · Elsevier eBooks · doi:10.1016/b978-0-323-85679-9.00015-5 · Cited by 18
Lu, W., Ren, S., Dong, W., Li, X., Zheng, Z., Jia, Y., & Xue, Y. (2022) · Acta Biochimica et Biophysica Sinica · doi:10.3724/abbs.2022055 · Cited by 11
“CDK1 dephosphorylation is required for the activation of CDK1-cyclin B1 complexes [54].”
BackgroundGu, J. (2025) · American Journal of Cancer Research · doi:10.62347/atcd4291 · Cited by 11
NOVEL TARGETS IN THE CELL CYCLE AND CELL CYCLE CHECKPOINTS
Pommier, Y. G., Yu, Q., & Kohn, K. W. (2002) · Elsevier eBooks · doi:10.1016/b978-012072651-6/50003-6 · Cited by 12
Liquiritigenin Induces Cell Cycle Arrest and Apoptosis in Lung Squamous Cell Carcinoma
Liu, Y., Wang, Y., Yang, Y., Quan, Y., & Guo, M. (2024) · Cell Biochemistry and Biophysics · doi:10.1007/s12013-024-01294-w · Cited by 10
“P21 can not only inhibit CDK1 activity by inhibiting the phosphorylation of CDK1 (Thr161) but also mediates Cyclin B degradation in the presence of DNA damage and maintains the cellular G2/M arrest [25, 26].”
Jiang, L., Ma, Y., Wang, J., Tao, X., & Wei, D. (2007) · Molecular Biology Reports · doi:10.1007/s11033-006-9044-4 · Cited by 10
Takahashi, H., Murai, Y., Tsuneyama, K., Nomoto, K., Okada, E., FUJITA, H., & Takano, Y. (2007) · Applied immunohistochemistry & molecular morphology · doi:10.1097/01.pai.0000213120.58472.57 · Cited by 10
Cazzalini, O., Perucca, P., Valsecchi, F., Stivala, L. A., Bianchi, L. C., Vannini, V., & Prosperi, E. (2004) · Histochemistry and Cell Biology · doi:10.1007/s00418-004-0650-8 · Cited by 10
“It is well known that p21 is responsible primarily for cell cycle arrest in the G1 phase (Deng et al. 1995); however, an involvement in the G2 phase arrest has also been demonstrated (Bunz et al. 1998; Smits et al. 2000).”
BackgroundOvercoming radioresistance in prostate cancer by targeting DNA damage repair
Matos, A. C., Lima, M. L. S. D. O., Miranda‐Gonçalves, V., Indraccolo, S., Jerónimo, C., & Saraiva, L. (2025) · Cancer Letters · doi:10.1016/j.canlet.2025.218183 · Cited by 10
2(±)-7,8,3′,4′,5′-pentamethoxyflavan induces G2/M phase arrest and apoptosis in HL60 cells
Ma, E., Li, Y., Zhang, W., Wang, X., Tai, W., Li, T., Zhang, L., & Ikejima, T. (2009) · Toxicology in Vitro · doi:10.1016/j.tiv.2009.05.001 · Cited by 10
Liu, Y., Liu, Y., Wang, L.-W., Huang, Y., Huang, P., Tsai, T., & Chen, Y.-J. (2016) · OncoTargets and Therapy · doi:10.2147/ott.s96355 · Cited by 9
“p21 is a potent cyclin-dependent kinase inhibitor that can inhibit Cdc2 activity to cause G2 arrest.(30) Our results”
BackgroundPKCβ1 regulates meiotic cell cycle in mouse oocyte
Yi, Z., Liang, Q., Meng, T., Li, J., Dong, M., Hou, Y., Ouyang, Y., Zhang, C., Schatten, H., Sun, Q., et al. (2019) · Cell Cycle · doi:10.1080/15384101.2018.1564492 · Cited by 9
“We also examined Cdc2 activity by detecting its Thr161 and Tyr15 phosphorylation state.”
BackgroundInfluentialJung, M.-S., Kim, W., Cho, J. W., Yang, W. H., & Chung, I. K. (2022) · Biochemical Journal · doi:10.1042/bcj20220391 · Cited by 9
p21 is Responsible for Ionizing Radiation-induced Bypass of Mitosis.
Zhang, X. R., Liu, Y. A., Sun, F. Z., Li, H., Lei, S. W., & Wang, J. F. (2016) · PubMed · doi:10.3967/bes2016.064 · Cited by 10
Weis, K. E., & Raetzman, L. T. (2016) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2016.09.027 · Cited by 10
Chen, X., Wang, K., Cederbaum, A. I., & Lu, Y. (2019) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2019.03.021 · Cited by 9
“P21 is an inhibitor of cell proliferation (30,31).”
BackgroundYao, C., Chow, J., Yang, C., Kuo, H.-C., Chang, C., Lee, H., Lai, I., Chuang, S., & Lai, G. (2016) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2016/3251046 · Cited by 10
“We then examined whether THL induced expression of CDK inhibitor such as p21, which suppresses Cdc2 activity [20].”
BackgroundLee, S. F., Hirpara, J. L., Qu, J., Yadav, S. K., Sachaphibulkij, K., & Pervaiz, S. (2021) · Cancer Letters · doi:10.1016/j.canlet.2021.11.025 · Cited by 8
Oncogenic pathways impinging on the G2-restriction point
Foijer, F., Simonis, M., van Vliet, M. H., Wessels, L. F. A., Kerkhoven, R. M., Sorger, P. K., & Riele, H. T. (2007) · Oncogene · doi:10.1038/sj.onc.1210724 · Cited by 10
“…S-phase cells, cells were incubated with 10mM 5-bromodeoxyuridine for 1 h and subsequently fixed in 70% ethanol in phosphate-buffered saline at 41C. Cells were stained with mouse anti-BrdU as described previously (Brugarolas et al., 1998) or stained for MPM2 positivity (Smits et al., 2000a).”
BackgroundMethodZou, L., Wang, Y., Hu, Y., Liu, L., Luo, L., Zhao, C., Zhuo, Y., Li, P., & Zhou, Q. (2023) · International Journal of Medical Sciences · doi:10.7150/ijms.90591 · Cited by 7
“In eukaryotic cells, inhibition of CDK1 phosphorylation (Thr-161) by P21 is considered to be a key process in inducing G2/M phase arrest [38, 41] and a series of studies have shown that cell cycle arrest induces senescence of NPCs [42, 43], suggesting that P21-regulated cell cycle arrest may…”
BackgroundCtIP is required for DNA damage-dependent induction ofP21
Liu, B., Cong, R., Peng, B., Zhu, B., Dou, G., Ai, H., Zhang, X., Wang, Z., & Xu, X. (2013) · Cell Cycle · doi:10.4161/cc.26810 · Cited by 7
“It exerts its functions primarily through inhibition of CDK2 and CDK1.(9,10) P21 binds to CDKs through its N-terminal Cy motif, and thereby inhibits phosphorylation and activation of CDKs and their substrates.”
Zeng, J., Zhang, H., Liu, Y., Sun, W., Yi, D., Zhu, L., Zhang, Y., Pan, X., Chen, Y., Zhou, Y., et al. (2020) · International Journal of Stem Cells · doi:10.15283/ijsc20033 · Cited by 7
Li, H., Wang, J., Huang, K., Zhang, T., Gao, L., Yang, S., Yi, W., Niu, Y., Liu, H., Wang, Z., et al. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.648045 · Cited by 9
p21CDKN1A and DNA Repair Systems: Recent Findings and Future Perspectives
Tillhon, M., Cazzalini, O., Dutto, I., Lucia, A., & Prosperi, E. (2013) · InTech eBooks · doi:10.5772/54173 · Cited by 7
Bird, R. C., & DeInnocentes, P. (2004) · PubMed · Cited by 6
Huynh, H. T., Nguyen, T., Panasci, L., & Do, P. (2004) · Cancer · doi:10.1002/cncr.20670 · Cited by 6
Renal Hyperplasia and Hypertrophy
Griffin, S., & Shankland, S. J. (2008) · Elsevier eBooks · doi:10.1016/b978-012088488-9.50030-9 · Cited by 5
Radiation Induced DNA Damage, Repair and Therapeutics
Harrison, L. (2013) · CRC Press eBooks · doi:10.1201/b14587-14 · Cited by 5
Nakamura, M., Wu, L., Griffin, J. D., Kojika, S., Goi, K., Inukai, T., & Sugita, K. (2018) · Leukemia Research · doi:10.1016/j.leukres.2018.07.022 · Cited by 4
“A uthor M anuscript A uthor M anuscript A uthor M anuscript A uthor M anuscript Notch1 induced expression of an activated form of cdc2 as indicated by phosphorylation on Thr161 in 32D cells.”
BackgroundInfluentialCellular Senescence in Cancer: Mechanisms, Roles in Tumor Progression, and Therapeutic Implications
Yan, J., Zhang, Y., Mao, G., Yu, J., Zhou, T., & Hao, J. (2025) · MedComm – Oncology · doi:10.1002/mog2.70029 · Cited by 3
Shin, H.-E., Lee, S., Choi, Y., Park, S., Kwon, S., Choi, J.-K., Seo, S., & Lee, Y. (2022) · Biomolecules & Therapeutics · doi:10.4062/biomolther.2022.090 · Cited by 3
“Indeed, p21 blocks G2/M transition by directly binding to the cyclin B-cdc2 complex or inhibiting phosphorylation at Thr161 of cdc2, which is required for its maximum activity (Smits et al., 2000; Taylor and Stark, 2001; Kreis et al., 2015).”
BackgroundProlonged cyclic strain inhibits human endothelial cell growth
Durante, W. (2016) · Frontiers in Bioscience-Elite · doi:10.2741/e761 · Cited by 3
Renal Hyperplasia and Hypertrophy
Brinkkoetter, P. T., Griffin, S., & Shankland, S. J. (2012) · Elsevier eBooks · doi:10.1016/b978-0-12-381462-3.00028-8 · Cited by 3
Mechanisms of G2 Phase Arrest in DNA Damage-Induced Checkpoint Response
Kuang, J., & Wang, R. (2009) · Humana Press eBooks · doi:10.1007/978-1-60761-178-3_3 · Cited by 4
Enter the nucleus to exit the cycle
Krenning, L., & Medema, R. H. (2014) · Cell Cycle · doi:10.4161/15384101.2014.948783 · Cited by 3
Self-citationDNA methylation as a driver of lung fibroblast senescence in COPD
Lyu, Y., de Vries, M., Banchero, M., Guryev, V., Timens, W., van den Berge, M., Sarno, F., Brandsma, C., & Woldhuis, R. R. (2025) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00035.2026 · Cited by 2
Cell Death in Response to Genotoxic Stress and DNA Damage
Lopez‐Bergami, P., & Ronai, Z. A. (2011) · Cambridge University Press eBooks · doi:10.1017/cbo9780511976094.008 · Cited by 3
PARP inhibitor response is enhanced in prostate cancer when XRCC1 expression is reduced
Goel, K., Venkatappa, V., Krieger, K. L., Chen, D., Sreekumar, A., & Gassman, N. R. (2025) · NAR Cancer · doi:10.1093/narcan/zcaf015 · Cited by 4
“6 E and F). p21 is one of the main targets of A TM and A TR DDR signaling, and it regulates G2 / M checkpoint activation and maintenance [ 31 ].”
Hung, H., Chow, P. K. H., Soo, K. C., Panasci, L. C., & Hung, N. T. (2005) · Journal of Cellular Physiology · doi:10.1002/jcp.20336 · Cited by 2
“Smits VA, Klompmaker R, Vallenius T, Rijksen G, Makela TP, Medema RH. 2000. p21 inhibits Thr161 phosphorylation of Cdc2 to enforce the G2 DNA damage checkpoint.”
BackgroundAdorisio, S., Fierabracci, A., Gigliarelli, G., Muscari, I., Cannarile, L., Liberati, A. M., Marcotullio, M. C., Riccardi, C., Curini, M., Robles‐Zepeda, R. E., et al. (2017) · Integrative Cancer Therapies · doi:10.1177/1534735417696721 · Cited by 3
“During G 1 /S transition and G 2 phase, p21 inhibits Cdk-activating kinase (CAK) and its consequent Thr116 phosphorylation.(29) The protein can also interact with the cyclin B1-Cdk1 complex in response to genotoxic stress, thus blocking activation by Cdc25 and CAK,(30) and sustain G 2 Figure 5.”
RetractedChen, Y., Yen, C., Yen, C., Farooqı, A. A., Chang, M., Chien, T., Tang, J., & Chang, H. (2026) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-026-05675-y · Cited by 1
“Reduced Thr161 phosphorylation and cyclin B1 level block CDC2 activation and trigger G2/M arrest [ 29 ], so p-CDC2 (Thr161) levels decline during G2/M arrest.”
InfluentialAlaoui‐Jamali, M. A., Saad, A., & Batist, G. (2012) · Springer eBooks · doi:10.1007/978-1-4614-4741-2_3 · Cited by 1
Prolonged cyclic strain inhibits human endothelial cell growth
Durante, W. (2015) · Frontiers in Bioscience-Elite · doi:10.2741/761 · Cited by 1
Effects of Amifostine on Apoptosis, Cell Cycle and Cytoprotection of Human Colon Cancer Cell Lines
Lee, E. J. (2023) · Journal of Experimental & Biomedical Sciences/Biomedical Science Letters · doi:10.15616/bsl.2023.29.4.287 · Cited by 1
Fruet, A. C. (2015) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.9.2015.tde-28052015-083539 · Cited by 5
Nakouzi, N. A. (2011) · theses.fr (ABES) · doi:10.70675/4e4b277az83fbz4562zbae0z9f48206f14aa · Cited by 1
Peterson, J. M. (2008) · The Research Repository @ WVU (West Virginia University) · doi:10.33915/etd.2713
Targeting cell cycle checkpoints to specifically kill cancer
Burgess, A. (2004) · The University of Queensland · doi:10.14264/107006
Stress-Activated Signal Transduction Pathways in DNA Damage Response
Alaoui‐Jamali, M. A., Scrivens, P. J., & Loignon, M. (2004) · doi:10.1007/978-1-59259-735-2_6
Downstream gene expression of wild type p53 tumor suppressor gene versus mutated and null p53
Aljabri, M. B. (2006) · NORA - Norwegian Open Research Archives
Papel de la conexina43 en el control de la proliferación de astrocitos y células de glioma
González, S. H. (2009) · Gredos (University of Salamanca) · doi:10.14201/gredos.76273
Investigation into the stability of WEE1 kinase in plants
Cook, G. S. (2012) · ORCA Online Research @Cardiff (Cardiff University)
Domínguez, D. J. G. (2013) · Gredos (University of Salamanca) · doi:10.14201/gredos.122988
Skorta, I. (2009) · OPUS Publication Server of the University of Stuttgart (University of Stuttgart) · doi:10.18419/opus-1857
Regulation of G2/M Transition in Mammalian Cells by Oxidative Stress
Li, G., Nair, S. S., Lees, S. J., & Booth, F. W. (2005) · ASME International Mechanical Engineering Congress and Exposition (IMECE) · doi:10.1115/imece2005-82349
Terret, M., & Verlhac, M. (2004) · OpenGrey (Institut de l'Information Scientifique et Technique)
Ribosome Biogenesis and cell cycle regulation: Effect of RNA Polymerase III inhibition
Grilli, S., & Derenzini, M. (2013)
An investigation of p53’s differential activation of cell cycle arrest and apoptosis
Zhang, Y. (2008) · eSpace (Curtin University)
Metadata
- Authors
- Smits, V. A. J., Klompmaker, R., Vallenius, T., Rijksen, G., Mäkelä, T. P., & Medema, R. H.
- Affiliations
- University Medical Center Utrecht (NL)
- University of Helsinki (FI)
- Corresponding author
- Medema, René H.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2000-09
- Volume
- 275
- Issue
- 39
- Pages
- 30638-30643
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2127397312
- Cited by
- 221
- References
- 41
- Citations by year
- 2026: 4 · 2025: 6 · 2024: 3 · 2023: 5 · 2022: 6 · 2021: 11 · 2020: 7 · 2019: 6 · 2018: 4 · 2017: 12 · 2016: 14 · 2015: 7 · 2014: 6 · 2013: 14 · 2012: 14
- FWCI
- 3.37
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- creativecommons.org/licenses/by/4.0/ (vor, 7349 d)
- Locations
- Journal of Biological Chemistry (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Utrecht University Repository (Utrecht University) (submittedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › DNA Repair Mechanisms
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Kinase Regulation and GTPase Signaling
- Keywords
- p21, cdc2, G2 checkpoint, DNA damage checkpoint, G2 cell cycle arrest, cyclin-dependent kinase inhibition, Chk1, Cdc25C, cell cycle regulation
- MeSH terms
- Cell Compartmentation, Cell Nucleus, DNA Damage, Models, Biological, Phosphorylation, Protein Binding, Threonine, G2 Phase, CDC2 Protein Kinase, Cyclins, Cyclin-Dependent Kinases, Cyclin B, Cyclin-Dependent Kinase Inhibitor p21
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.